Asklerol 3% Injection 2Ml

Asklerol 3% Injection 2ml may interact with the following medicines:

• Antihypertensive medicines (amlodipine, losartan): Concomitant use with Asklerol 3% Injection 2ml may increase the risk of low blood pressure, dizziness, or fainting during and after the procedure. Your doctor may monitor your blood pressure closely during treatment.
• Anticoagulants and antiplatelet medicines (warfarin, heparin, aspirin, clopidogrel): Taking these medicines with Asklerol 3% Injection 2ml may increase the risk of bruising, bleeding, or injection site haematoma. Your doctor may monitor you for bleeding-related complications.
• Other sclerosing agents or local anaesthetics: Concurrent administration with Asklerol 3% Injection 2ml may increase the risk of local irritation, inflammation, or tissue-related reactions. Your doctor may decide the safest treatment approach based on your condition.

Asklerol 3% Injection 2ml interacts with the following diseases:

• Thromboembolic disease: Patients with active blood clots, deep vein thrombosis, or a history of pulmonary embolism may have an increased risk of worsening clot-related complications after receiving Asklerol 3% Injection 2ml. Your doctor may carefully assess your condition before starting treatment.
• Peripheral arterial disease: Reduced blood flow in patients with peripheral arterial disease may increase the risk of poor healing, tissue damage, or skin necrosis at the injection site after treatment with Asklerol 3% Injection 2ml.
• Asthma or severe allergic disorders: Patients with asthma or severe allergies may have a higher risk of hypersensitivity or allergic reactions, including severe reactions such as breathing difficulty or anaphylaxis, after administration of Asklerol 3% Injection 2ml.
• Reduced mobility or prolonged immobilisation: Patients who are unable to walk properly or remain immobile for long periods may have a higher risk of developing venous thrombosis after treatment with Asklerol 3% Injection 2ml. Your doctor may recommend walking and compression therapy after the procedure to help improve circulation.

The dose of Asklerol 3% Injection 2ml is decided by the doctor depending on the size, number, and location of the affected veins. This medicine should only be administered by a trained healthcare professional. Follow your doctor’s instructions carefully and attend follow-up visits if advised.

As Asklerol 3% Injection 2ml is administered by a trained healthcare professional, overdose is unlikely. However, excess administration may increase the risk of local reactions such as severe pain, swelling, irritation, or tissue damage around the injection site. Inform your doctor if you notice any unusual or worsening symptoms after treatment.

As Asklerol 3% Injection 2ml is administered by a healthcare professional during scheduled treatment sessions, the likelihood of a missed dose is low. If you miss an appointment, contact your doctor to reschedule the treatment session.